Chan AT - Search Results

1

Advanced technologies for studying circulating tumor cells at the protein level.

Chan CM, Au TC, Chan AT, Ma BB, Tsui NB, Ng SS, Hui EP, Chan LW, Ho WS, Yung BY, Wong SC. Chan CM, et al. Among authors: chan lw, chan at. Expert Rev Proteomics. 2013 Dec;10(6):579-89. doi: 10.1586/14789450.2013.858021. Expert Rev Proteomics. 2013. PMID: 24206230 Review.

2

Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.

Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT. Wong SC, et al. Among authors: chan cm, chan ak, chan at. Clin Cancer Res. 2009 Feb 1;15(3):1005-12. doi: 10.1158/1078-0432.CCR-08-1515. Clin Cancer Res. 2009. PMID: 19188172

3

Advanced proteomic technologies for cancer biomarker discovery.

Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT. Wong SC, et al. Among authors: chan cm, chan as, chan at. Expert Rev Proteomics. 2009 Apr;6(2):123-34. doi: 10.1586/epr.09.1. Expert Rev Proteomics. 2009. PMID: 19385940 Review.

4

Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients.

Wong CS, Cheung MT, Ma BB, Pun Hui E, Chan AC, Chan CK, Lee KC, Cheuk W, Lam MY, Wong MC, Chan CM, Chan JK, Chan AT. Wong CS, et al. Among authors: chan cm, chan jk, chan ac, chan at, chan ck. Int J Surg Pathol. 2008 Apr;16(2):119-26. doi: 10.1177/1066896907311901. Epub 2008 Apr 2. Int J Surg Pathol. 2008. PMID: 18387990

5

Targeting tumor hypoxia in nasopharyngeal carcinoma.

Hong B, Lui VW, Hashiguchi M, Hui EP, Chan AT. Hong B, et al. Among authors: chan at. Head Neck. 2013 Jan;35(1):133-45. doi: 10.1002/hed.21877. Epub 2011 Nov 22. Head Neck. 2013. PMID: 22106024 Review.

6

Clinical significance of frizzled homolog 3 protein in colorectal cancer patients.

Wong SC, He CW, Chan CM, Chan AK, Wong HT, Cheung MT, Luk LL, Au TC, Chiu MK, Ma BB, Chan AT. Wong SC, et al. Among authors: chan cm, chan ak, chan at. PLoS One. 2013 Nov 8;8(11):e79481. doi: 10.1371/journal.pone.0079481. eCollection 2013. PLoS One. 2013. PMID: 24255701 Free PMC article.

7

Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinic.

Raghupathy R, Hui EP, Chan AT. Raghupathy R, et al. Among authors: chan at. Am Soc Clin Oncol Educ Book. 2014:149-53. doi: 10.14694/EdBook_AM.2014.34.149. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857071 Free article. Review.

8

Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer.

Loong HH, Ma BB, Chan AT. Loong HH, et al. Among authors: chan at. Hematol Oncol Clin North Am. 2008 Dec;22(6):1267-78, x. doi: 10.1016/j.hoc.2008.08.012. Hematol Oncol Clin North Am. 2008. PMID: 19010273 Review.

9

Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells.

Sung FL, Poon TC, Hui EP, Ma BB, Liong E, To KF, Huang DP, Chan AT. Sung FL, et al. Among authors: chan at. In Vivo. 2005 Jan-Feb;19(1):237-45. In Vivo. 2005. PMID: 15796181 Free article.

10

Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

Wong CS, Wong VW, Chan CM, Ma BB, Hui EP, Wong MC, Lam MY, Au TC, Chan WH, Cheuk W, Chan AT. Wong CS, et al. Among authors: chan cm, chan wh, chan at. Oncol Rep. 2008 Jul;20(1):89-98. Oncol Rep. 2008. PMID: 18575723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,222 results

Search Page